Comanche Biopharma is a drug development company that uses pre-clinical biopharmaceutical research with the goal of lowering risks associated with pregnancy. With a mission to create accessible therapies that treat the root cause of preeclampsia, Comanche Biopharma designed molecules that decrease excess protein production, or sFlt1, as the biggest target of the disease. Comanche Biopharma was founded by Mike Young and Thomas Scott Johnson in 2020 and is headquartered in Concord, MA.

Register for Details

For more details on financing and valuation for Comanche Biopharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Comanche Biopharma

Forge green plus iconForge green minus icon

What is Comanche Biopharma's IPO price?

The IPO price for Comanche Biopharma will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Comanche Biopharma?

Comanche Biopharma is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Comanche Biopharma shares pre-IPO?

If you own Comanche Biopharma pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Comanche Biopharma a publicly traded company?

Comanche Biopharma is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Comanche Biopharma founded?

Comanche Biopharma was founded in 2020.

Who are Comanche Biopharma's major investors?

New Enterprise Associates
GV
Atlas Venture
F-Prime Capital
Lilly Asia Ventures
Longview Healthcare Ventures
Broadview Ventures
Population Health Partners
Updated on: Jun 22, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.